Mahdi Karimi
- Biomaterials top 0.2%
- Nanoparticle-Based Drug Delivery 15
- Pharmaceutical Science top 0.5%
- Advanced Drug Delivery Systems 4
- Molecular Medicine top 1%
- Biomedical Engineering top 0.5%
- Graphene and Nanomaterials Applications 12
- Nanoplatforms for cancer theranostics 8
- Biosensors and Analytical Detection 4
- Rehabilitation top 1%
-
- RNA Interference and Gene Delivery 12
- Advanced biosensing and bioanalysis techniques 9
-
- Neuroscience and Neural Engineering 4
- Co-authors
- Michael R. HamblinParham Sahandi ZangabadAmir GhasemiSeyed Masoud Moosavi BasriHamed MirshekariAmir Reza ArefSajad BahramiMohammad Sadegh Amiri
- Partner nations
- IranUnited StatesChina
In The Last Decade
Mahdi Karimi
53 papers receiving 6.7k citations
Hit Papers
Peers
Comparison fields: 5 of 163
- Biomaterials 2.2k
- Pharmaceutical Science 487
- Molecular Medicine 389
- Biomedical Engineering 3.3k
- Rehabilitation 358
Countries citing papers authored by Mahdi Karimi
This map shows the geographic impact of Mahdi Karimi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mahdi Karimi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mahdi Karimi more than expected).
Fields of papers citing papers by Mahdi Karimi
This network shows the impact of papers produced by Mahdi Karimi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mahdi Karimi. The network helps show where Mahdi Karimi may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Mahdi Karimi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 17 | |
| 2 | 2024 | 0 | |
| 3 | 2023 | 50 | |
| 4 | 2023 | 6 | |
| 5 | 2022 | 10 | |
| 6 | 2021 | 13 | |
| 7 | 2021 | 29 | |
| 8 | Carbon Nanotubes: Smart Drug/Gene Delivery Carriersbreakdown → | 2021 | 268 |
| 9 | Applications of Graphene and Graphene Oxide in Smart Drug/Gene Delivery: Is the World Still Flat? | 2020 | 3 |
| 10 | 2020 | 172 | |
| 11 | 2019 | 94 | |
| 12 | 2017 | 67 | |
| 13 | Nanomedicine and advanced technologies for burns: Preventing infection and facilitating wound healingbreakdown → | 2017 | 431 |
| 14 | 2016 | 26 | |
| 15 | 2016 | 121 | |
| 16 | 2016 | 153 | |
| 17 | 2015 | 40 | |
| 18 | 2015 | 98 | |
| 19 | Antimicrobial strategies centered around reactive oxygen species – bactericidal antibiotics, photodynamic therapy, and beyondbreakdown → | 2013 | 868 |
| 20 | 2013 | 48 |
About Mahdi Karimi
Mahdi Karimi is a scholar working on Biomaterials, General Energy and Archeology, having authored 56 papers that have together received 6.8k indexed citations. Recurring topics across this work include Nanoparticle-Based Drug Delivery (15 papers), RNA Interference and Gene Delivery (12 papers), Graphene and Nanomaterials Applications (12 papers), Advanced biosensing and bioanalysis techniques (9 papers), Nanoplatforms for cancer theranostics (8 papers), Neuroscience and Neural Engineering (4 papers), Biosensors and Analytical Detection (4 papers) and Advanced Drug Delivery Systems (4 papers). The work is most often cited by research in Biomaterials (2.2k citations), Pharmaceutical Science (487 citations) and Molecular Medicine (389 citations). Mahdi Karimi has collaborated with scholars based in Iran, United States and China. Frequent co-authors include Michael R. Hamblin, Parham Sahandi Zangabad, Amir Ghasemi, Seyed Masoud Moosavi Basri, Hamed Mirshekari, Amir Reza Aref, Sajad Bahrami, Mohammad Sadegh Amiri, Pinar Avci and Navid Rabiee.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.